Higher vessel densities in retinoblastoma with local invasive growth and metastasis
- PMID: 14742245
- PMCID: PMC1602251
- DOI: 10.1016/S0002-9440(10)63129-X
Higher vessel densities in retinoblastoma with local invasive growth and metastasis
Abstract
In this study, the importance of angiogenesis (the growth of new blood vessels from existing ones) for the growth of retinoblastoma was investigated by a retrospective immunohistochemical analysis. An individual vessel index for each tumor was determined using the endothelial-specific antibody CD 31 for vessel staining. The obtained data were correlated with clinical features, pathohistological characteristics, and the presence of metastasis. In 107 retinoblastomas collected between 1980 and 1990, we found no difference in the vessel densities between uni- and bilateral retinoblastomas (P = 0.41). However, tumors that had invaded the chorioid and/or the optic nerve statistically showed higher vessel densities than tumors without local invasive growth (P = 0.05 and P = 0.024). A tendency of higher vessel densities in retinoblastomas presenting with metastasis at the time of diagnosis was observed (P = 0.11). Based on this observation, we proceeded to examine all retinoblastomas presenting with metastasis at the time of diagnosis. These included patients that were treated between 1968 and 1993. The 18 investigated retinoblastomas had significantly higher vessel densities than all other retinoblastomas presenting without metastasis (P = 0.025). Our data indicate that in retinoblastoma, blood vessels are essential for local and systemic invasive growth. Therefore, an anti-angiogenic therapy could be considered in the multimodal therapy concept for retinoblastomas with invasive growth, both locally and systemically.
Figures


Similar articles
-
Nm23 expression in retinoblastoma.Ocul Immunol Inflamm. 2004 Jun;12(2):127-35. doi: 10.1080/09273940490895335. Ocul Immunol Inflamm. 2004. PMID: 15512982
-
Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.Arch Ophthalmol. 2008 Jul;126(7):953-8. doi: 10.1001/archopht.126.7.953. Arch Ophthalmol. 2008. PMID: 18625942
-
Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.Retina. 2008 Mar;28(3 Suppl):S81-6. doi: 10.1097/IAE.0b013e318150d6f0. Retina. 2008. PMID: 18317352
-
Involvement of RB gene family in tumor angiogenesis.Oncogene. 2006 Aug 28;25(38):5326-32. doi: 10.1038/sj.onc.1209631. Oncogene. 2006. PMID: 16936754 Review.
-
[Retinoblastoma and retinocytoma (retinoma)].Pathologe. 2017 Nov;38(6):507-514. doi: 10.1007/s00292-017-0384-8. Pathologe. 2017. PMID: 29043448 Review. German.
Cited by
-
Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.Open Ophthalmol J. 2008 Apr 2;2:62-7. doi: 10.2174/1874364100802010062. Open Ophthalmol J. 2008. PMID: 19517030 Free PMC article.
-
Expression of C-kit in retinoblastoma: a potential therapeutic target.Br J Ophthalmol. 2007 Nov;91(11):1532-6. doi: 10.1136/bjo.2007.119651. Epub 2007 Jun 25. Br J Ophthalmol. 2007. PMID: 17591671 Free PMC article.
-
The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.Neoplasia. 2012 Dec;14(12):1213-22. doi: 10.1593/neo.121422. Neoplasia. 2012. PMID: 23308053 Free PMC article.
-
Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.J Exp Clin Cancer Res. 2016 Nov 4;35(1):171. doi: 10.1186/s13046-016-0451-7. J Exp Clin Cancer Res. 2016. PMID: 27814771 Free PMC article.
-
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.BMC Cancer. 2010 Sep 22;10:504. doi: 10.1186/1471-2407-10-504. BMC Cancer. 2010. PMID: 20860824 Free PMC article.
References
-
- Kock E, Naeser P. Retinoblastoma in Sweden 1958–1971: a clinical and histopathological study. Acta Ophthalmol Copenh. 1979;57:344–350. - PubMed
-
- Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 1990;97:1143–1147. - PubMed
-
- Hinds PW. The retinoblastoma tumor suppressor protein. Curr Opin Genet Dev. 1995;5:79–83. - PubMed
-
- Tso MOM, Zimmermann LE, Fine BS. The nature of retinoblastoma II: photoreceptor differentiation: an electron microscopy study. Am J Ophthalmol. 1970;69:350–359. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources